New Stock News | Changzhou Fusion New Material (688503.SH) plans to list in Hong Kong. The China Securities Regulatory Commission requires supplementary information on the progress of state-owned shareholders fulfilling the management of state-owned shares identification and other matters.
According to the Hong Kong Stock Exchange disclosed on January 14th, Poly materials have submitted their application to be listed on the main board of the Hong Kong Stock Exchange, with Huatai International and Jefferies acting as its joint sponsors.
The China Securities Regulatory Commission issued the "Supplementary Materials Requirements for Overseas Issuance and Listing Registration (March 3, 2026 to March 13, 2026)". The International Department of the China Securities Regulatory Commission has issued supplementary materials requirements for 8 companies, including requiring Changzhou Fusion New Material (688503.SH) to provide further clarification on the progress of state-owned shareholders in implementing state-owned share identification and other state asset management procedures. According to the disclosure by the Hong Kong Stock Exchange on January 14th, Changzhou Fusion New Material submitted an application to the Hong Kong Stock Exchange's main board, with Huatai International and Jefferies acting as its joint sponsors.
The China Securities Regulatory Commission has requested Changzhou Fusion New Material to provide further clarification on the following issues and to have lawyers verify and provide clear legal opinions:
The progress of state-owned shareholders in implementing state-owned share identification and other state asset management procedures.
According to the prospectus, the company is a research and development-driven advanced materials company located in China. Since its establishment in 2015, the company has continuously invested in research and development to deepen its professional capabilities in the field of advanced materials, especially in photovoltaic conductive pastes. The company's capabilities include the synthesis of inorganic and organic materials, formulation design, manufacturing processes, analysis, and application development, and have established a diversified product portfolio. In addition, the company maintains a stable and efficient operational management system to support the continuous progress and sustainable growth of the business.
Related Articles

GENSCRIPT BIO (01548) releases annual financial results, with a net loss attributable to shareholders of 533 million USD, a year-on-year shift from profit to loss.

SINOPEC SEG (02386) releases annual results, with shareholders' profit of 1.798 billion yuan, a year-on-year decrease of 27.1%.

CITIC SEC: The impact of rising PET prices is controllable, and beverage companies are expected to reduce hedging costs.
GENSCRIPT BIO (01548) releases annual financial results, with a net loss attributable to shareholders of 533 million USD, a year-on-year shift from profit to loss.

SINOPEC SEG (02386) releases annual results, with shareholders' profit of 1.798 billion yuan, a year-on-year decrease of 27.1%.

CITIC SEC: The impact of rising PET prices is controllable, and beverage companies are expected to reduce hedging costs.






